Cargando…

Folate-Receptor Positive Circulating Tumor Cell Is a Potential Diagnostic Marker of Prostate Cancer

Folate-receptor positive circulating tumor cells (FR+CTCs) shows an important role in the diagnosis and dynamic monitoring for many solid tumors; however, the application of FR+CTCs in prostate cancer remains unclear. We explored the potential application of FR+CTCs in this retrospective study. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lian, Shenyi, Yang, Lujing, Feng, Qin, Wang, Ping, Wang, Yue, Li, Zhongwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531518/ https://www.ncbi.nlm.nih.gov/pubmed/34692484 http://dx.doi.org/10.3389/fonc.2021.708214

Ejemplares similares

Folate receptor-positive circulating tumor cell count, lymphocyte count and derived neutrophil-to- lymphocyte ratio for diagnosing lung cancer relapse
por: Wang, Huanrong, et al.
Publicado: (2023)

Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer
por: Cheng, Hao, et al.
Publicado: (2022)

Evaluation of colorectal cancer liver metastases based on liquid biopsy combined with folate receptor– Positive circulating tumor cells and HSP90
por: Huang, Maosen, et al.
Publicado: (2022)

Preoperative levels of folate receptor-positive circulating tumor cells in different subtypes of early-stage lung adenocarcinoma: Predictive value for determining extent of surgical resection
por: Zhou, Chao, et al.
Publicado: (2023)

Preoperative Folate Receptor-Positive Circulating Tumor Cells Are Associated With Occult Peritoneal Metastasis and Early Recurrence in Gastric Cancer Patients: A Prospective Cohort Study
por: Zeng, Ci Dian Dan, et al.
Publicado: (2022)

Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients
por: Li, Hang, et al.
Publicado: (2021)

Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer
por: Xie, Xiaohong, et al.
Publicado: (2021)

The utility of folate receptor-positive circulating tumor cell in cancer diagnosis in the elderly population
por: Li, Na, et al.
Publicado: (2019)

The combination of folate receptor-positive circulating tumor cells and serum tumor markers suggests a histological diagnosis of lung cancer
por: Lv, Xing, et al.
Publicado: (2022)

New Screening Test Improves Detection of Prostate Cancer Using Circulating Tumor Cells and Prostate-Specific Markers
por: Ried, Karin, et al.
Publicado: (2020)

Validation of the diagnostic efficiency of folate receptor-positive circulating tumor cells in lung cancers: a prospective observational study
por: Liu, Jingbo, et al.
Publicado: (2019)

Folate receptor‐positive circulating tumor cells in the preoperative diagnosis of indeterminate pulmonary nodules
por: Li, Zhixin, et al.
Publicado: (2022)

Prospects in Folate Receptor-Targeted Radionuclide Therapy
por: Müller, Cristina, et al.
Publicado: (2013)

Isolation and characterization of circulating tumor cells in prostate cancer
por: Diamond, Elan, et al.
Publicado: (2012)

Prognostic Relevance of Estrogen Receptor Status in Circulating Tumor Cells in Breast Cancer Patients Treated With Endocrine Therapy
por: Zhou, Ying, et al.
Publicado: (2022)

Decitabine Sensitizes the Radioresistant Lung Adenocarcinoma to Pemetrexed Through Upregulation of Folate Receptor Alpha
por: Wang, Yuqing, et al.
Publicado: (2021)

Detection of folate receptor‐positive circulating tumor cells as a biomarker for diagnosis, prognostication, and therapeutic monitoring in breast cancer
por: Wu, Qian, et al.
Publicado: (2021)

Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study
por: Zhou, Qiang, et al.
Publicado: (2023)

The value of folate receptor‐positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics
por: Xu, Yunjian, et al.
Publicado: (2023)

PRL-3 and MMP9 Expression and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells From Patients With Colorectal Cancer: Potential Value in Clinical Practice
por: Hong, Xiao-Cui, et al.
Publicado: (2022)

Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma
por: Lei, Yongrong, et al.
Publicado: (2021)

Targeted Nanoparticles for Fluorescence Imaging of Folate Receptor Positive Tumors
por: Marko, Aimee J., et al.
Publicado: (2020)

Clinical diagnostic biomarker “circulating tumor cells” in breast cancer - a meta-analysis
por: Bai, Shiyan, et al.
Publicado: (2023)

Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer
por: Wang, Lin, et al.
Publicado: (2017)

Adhesion receptors as therapeutic targets for circulating tumor cells
por: Li, Jiahe, et al.
Publicado: (2012)

Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells
por: Pifano, Marina, et al.
Publicado: (2017)

A Multivariate Diagnostic Model Based on Urinary EpCAM-CD9-Positive Extracellular Vesicles for Prostate Cancer Diagnosis
por: Dai, Yibei, et al.
Publicado: (2021)

Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment
por: Jia, Zhenyu, et al.
Publicado: (2019)

A preliminary study of the clinical significance of folate receptor-positive circulating tumor cell in the management of hepatobiliary-pancreatic cancers
por: He, Yong-gang, et al.
Publicado: (2020)

The Potential Diagnostic and Prognostic Value of Circulating MicroRNAs in the Assessment of Patients With Prostate Cancer: Rational and Progress
por: Samami, Elham, et al.
Publicado: (2022)

Potential Applications of Circulating Tumor DNA Technology as a Cancer Diagnostic Tool
por: Kunnath, Anil P, et al.
Publicado: (2019)

Aneuploid subtypes of circulating tumor cells and circulating tumor-derived endothelial cells predict the overall survival of advanced lung cancer
por: Zhang, Jie, et al.
Publicado: (2023)

Investigation of folate-conjugated fluorescent silica nanoparticles for targeting delivery to folate receptor-positive tumors and their internalization mechanism
por: Yang, Hong, et al.
Publicado: (2011)

The value of folate receptor-positive circulating tumour cells as a diagnostic biomarker for lung cancer: a systematic review and meta-analysis
por: Chen, Fangjun, et al.
Publicado: (2023)

RBM10 Deficiency Is Associated With Increased Immune Activity in Lung Adenocarcinoma
por: Liu, Bing, et al.
Publicado: (2021)

Circulating Cell-Free DNA-Based Detection of Tumor Suppressor Gene Copy Number Loss and Its Clinical Implication in Metastatic Prostate Cancer
por: Dong, Xiaoxi, et al.
Publicado: (2021)

Folate intake, alcohol consumption, and the methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism: influence on prostate cancer risk and interactions
por: Kobayashi, Lindsay C., et al.
Publicado: (2012)

Targeting folate receptor β positive tumor-associated macrophages in lung cancer with a folate-modified liposomal complex
por: Tie, Yan, et al.
Publicado: (2020)

Diagnostic value of tumor-associated autoantibodies panel in combination with traditional tumor markers for lung cancer
por: Xu, Yu, et al.
Publicado: (2023)

Circulating tumor cells as a preoperative risk marker for occult metastases in patients with resectable cholangiocarcinoma
por: Fründt, Thorben, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bb27nomrncg9voa1faetg8e6vm